从涉及内源性治疗分析剂生物分析的监管提交中吸取的教训
Chongwoo Yu1, Wenlei Jiang2, Murali Matta1
1Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS), Center for Drug Evaluation & Research (CDER), US FDA), Silver Spring, MD 20993, USA.
Bioanalysis
|December 13, 2023
概括
当药物化合物与身体的自然物质无法区分时,对内源性治疗分析物的准确测量是具有挑战性的. 本文介绍了在药物开发中成功进行生物分析的案例和策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 分析化学 分析化学
- 生物化学 生物化学
背景情况:
- 内源性治疗分析剂 (例如,激素,维生素) 是自然存在的物质,对身体功能至关重要.
- 在药物开发过程中,对这些分析物的准确量化是至关重要的.
- 从内源性对应物中区分给药的外源性分析物是一个重大的生物分析挑战.
研究的目的:
- 在药物开发中展示内源性治疗分析物生物分析的现实案例.
- 突出在生物分析的这个专业领域共同的挑战和经验教训.
- 为处理内源分析物生物分析提供实际的监管策略.
主要方法:
- 从药物开发计划中收集和介绍病例研究.
- 分析在将外源药物与内源分析物区分时遇到的挑战.
- 对监管考虑和最佳实践的审查.
主要成果:
- 由于外源和内源分析物的不可区分性质,在生物分析中存在明显的困难.
- 确定了包括方法验证,矩阵效应和监管接受在内的关键挑战.
- 提供了关于在真实药物开发场景中使用的成功策略的见解.
结论:
- 对内源性治疗分析物的成功生物分析需要仔细的方法开发和验证.
- 对于涉及内源性分析物的提交,早期解决监管期望至关重要.
- 从案例中学到的教训为未来的药物开发项目提供了宝贵的指导.
相关概念视频
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
130
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
130
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K


